Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Fk 614

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Fk-614, 193012-35-0, Fk614, Atx08-001, V5q32bzx79, 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide
    Molecular Formula
    C21H23Cl2N3O3S
    Molecular Weight
    468.4  g/mol
    InChI Key
    UYGZODVVDUIDDQ-UHFFFAOYSA-N
    FDA UNII
    V5Q32BZX79
    FK614 has been used in trials studying the treatment of Diabetes Mellitus.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    3-[(2,4-dichlorophenyl)methyl]-2-methyl-N-pentylsulfonylbenzimidazole-5-carboxamide
    2.1.2 InChI
    InChI=1S/C21H23Cl2N3O3S/c1-3-4-5-10-30(28,29)25-21(27)15-7-9-19-20(11-15)26(14(2)24-19)13-16-6-8-17(22)12-18(16)23/h6-9,11-12H,3-5,10,13H2,1-2H3,(H,25,27)
    2.1.3 InChI Key
    UYGZODVVDUIDDQ-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CCCCCS(=O)(=O)NC(=O)C1=CC2=C(C=C1)N=C(N2CC3=C(C=C(C=C3)Cl)Cl)C
    2.2 Other Identifiers
    2.2.1 UNII
    V5Q32BZX79
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3 H-benzimidazole-5-carboxamide

    2. Fk614 Cpd

    2.3.2 Depositor-Supplied Synonyms

    1. Fk-614

    2. 193012-35-0

    3. Fk614

    4. Atx08-001

    5. V5q32bzx79

    6. 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide

    7. Unii-v5q32bzx79

    8. Fk 614

    9. Schembl682052

    10. Chembl3545278

    11. Dtxsid60940978

    12. Bdbm50469398

    13. Db12557

    14. Sb16865

    15. 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3 H-benzimidazole-5-carboxamide

    16. 1-[(2,4-dichlorophenyl)methyl]-2-methyl-n-(pentane-1-sulfonyl)-1h-benzimidazole-6-carboximidic Acid

    17. Hy-101292

    18. Cs-0021092

    19. A857643

    20. Q27291562

    21. 1-(2,4-dichlorobenzyl)-2-methyl-6-(1-pentanesulfonylcarbamoyl)benzimidazole

    22. 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxami-de

    23. 3-[(2,4-dichlorophenyl)methyl]-2-methyl-n-pentylsulfonylbenzimidazole-5-carboxamide

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 468.4 g/mol
    Molecular Formula C21H23Cl2N3O3S
    XLogP35.3
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count8
    Exact Mass467.0837182 g/mol
    Monoisotopic Mass467.0837182 g/mol
    Topological Polar Surface Area89.4 Ų
    Heavy Atom Count30
    Formal Charge0
    Complexity688
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.